Latest Emtricitabine Stories

2008-10-22 09:00:10

BRIDGEWATER, N.J., Oct. 22 /PRNewswire/ -- The FDA has granted PREZISTA (darunavir) tablets, a protease inhibitor, approval for an expanded indication for once-daily dosing as part of HIV combination therapy in treatment-naive adults (those who have never taken HIV medication before).

2008-08-14 03:00:47

Gilead Sciences has announced that the FDA has granted marketing approval for Viread for the treatment of chronic hepatitis B, a liver disease caused by the hepatitis B virus. Viread is now also indicated for the treatment of chronic hepatitis B in adults.

2008-08-08 09:01:34

Ardea Biosciences has presented positive data from its completed Phase IIa proof-of-concept monotherapy study of RDEA806, the company's investigational non-nucleoside reverse transcriptase inhibitor for patients with human immunodeficiency virus, demonstrating robust antiviral activity with a well-tolerated profile.

2008-08-07 15:00:12

MEXICO CITY and SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc.

2008-08-05 12:01:07

MEXICO CITY, Aug. 5 /PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd.

2008-07-22 18:00:55

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that it has begun enrolling patients in a Phase III clinical trial of its investigational antiretroviral agent elvitegravir (GS 9137), a novel oral integrase inhibitor that is being evaluated for the treatment of HIV-1 infection.

2008-07-17 09:01:20

YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in treatment-naive adults with HIV-1, are now recruiting patients.

Word of the Day
  • The governor of a province or people.
The word 'ethnarch' comes from a Greek word meaning 'ruler of a tribe or nation'.